Welcome to our dedicated page for EARTH LIFE SCIENCES news (Ticker: CLTS), a resource for investors and traders seeking the latest updates and insights on EARTH LIFE SCIENCES stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect EARTH LIFE SCIENCES's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of EARTH LIFE SCIENCES's position in the market.
Earth Life Sciences Inc. (OTC: CLTS) is set to launch its VivaHealth platform targeting Asian elderly communities in North America. With a projected revenue of $17.9 million during the initial phase and expectations to triple monthly revenue to $4.35 million in future quarters, the company aims for EBITDA profitability by 2024. The platform integrates various lifestyle services, catering to an aging population that values self-care. With over 5 million Chinese Americans in the U.S., there is significant market potential for the services provided.
Earth Life Sciences Inc. (CLTS) is focusing on the VivaHealth platform, targeting the Asian elderly communities in North America due to their significant spending power. The platform integrates various life services, particularly in skincare and wellness, leveraging big data and internet technology. With Baby Boomers controlling 70% of U.S. disposable income, demand is expected to surge. The Company aims to launch VIVA USA across hundreds of cities, enhancing access to self-care for elderly Asians. The initiative is part of a strategic move into the fast-growing Personal Care segment of the healthcare industry.
Earth Life Sciences has announced the progress of its VivaHealth platform, which is currently in Phase 1 testing. Aimed at senior Asian communities in North America, this smart life service platform focuses on lifestyle services such as skincare, beauty, and traditional massages. With the healthcare sector projected to reach $10.059 trillion, the platform is set to launch across the U.S., serving millions. The company emphasizes its commitment to enhancing shareholder value through this initiative.
Earth Life Sciences Inc. (OTC PINK:CLTS) announces its acquisition of VIVA Health, launching www.VivaBestHealth.com to enhance healthcare services in the US. The platform utilizes AI and big data for optimized healthcare staff management and service delivery, aiming to standardize processes and improve service quality. Initial funding of US$1.1 million is planned for expansion. The US healthcare market is projected to exceed $10.059 trillion by 2022, highlighting significant growth potential.
Earth Life Sciences (OTC PINK:CLTS) has signed an acquisition agreement with VIVA Health HK Limited to launch the VIVA USA smart healthcare platform in the United States. This strategic move positions the company to tap into the rapidly growing healthcare market, leveraging AI and big data to enhance service efficiency. VIVA aims to standardize training and service processes, targeting millions of users across various cities. The initial funding of US$1.1 million will support this expansion, and the company plans to rebrand as VIVA USA.
FAQ
What is the market cap of EARTH LIFE SCIENCES (CLTS)?
